Vor Biopharma (VOR) Non-cash Items (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Non-cash Items data on file, last reported at $109.8 million in Q1 2026.

• Non-cash Items for Q1 2026 came in at $109.8 million, up 846.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $109.8 million (up 846.55% YoY), and the FY2025 annual result was $113.4 million, up 53644.08% from the prior year.
• Non-cash Items fell to $109.8 million in Q1 2026 per VOR's latest filing, from $113.4 million in the prior quarter.
• Over five years, Non-cash Items peaked at $113.4 million in Q4 2025 and troughed at $211000.0 in Q4 2024.
• A 5-year average of $32.1 million and a median of $17.0 million in 2023 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2023 and 2025: Non-cash Items plunged 93.32% in 2023, then soared 53644.08% in 2025.
• A 5-year view of Non-cash Items shows it stood at $14.9 million in 2022, then sank by 93.32% to $999000.0 in 2023, then slumped by 78.88% to $211000.0 in 2024, then soared by 53644.08% to $113.4 million in 2025, then decreased by 3.17% to $109.8 million in 2026.
• Business Quant data shows VOR's Non-cash Items at $109.8 million in Q1 2026, $113.4 million in Q4 2025, and $82.3 million in Q3 2025.